Clinical Trials Directory

Trials / Completed

CompletedNCT00433121

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

Discontinuation of Antipsychotics and Antidepressants Among Patients With Dementia and BPSD Living in Nursing Homes - an Open Study.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Sykehuset Innlandet HF · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this study is to discontinue antipsychotics and antidepressants, and to study its effect on Behavioural- and Psychological Symptoms in Dementia (BPSD).

Detailed description

Patients with dementia have cognitive deficits, but also hallucinations, delusions, agitation, aggression and apathy. These symptoms are called Behavioural- and Psychological Symptoms in Dementia (BPSD), and are difficult to treat. Antipsychotic and antidepressant medication is in use, despite its lack of clinical evidence. We will discontinue antipsychotics in one group of 12 patients and antidepressants in one group of 12 patients. Patients should have dementia of Alzheimer- or vascular origin. They should live in Nursing Homes and have no other psychiatric disease for which they receive psychotropic drug. They will be registered with 7 different questionnaires at baseline and after 3, 6, 12 and 24 weeks. The study period is 24 weeks. The questionnaires are filled in by the patients and the nurses at the nursing homes. This is an open labelled study with no control group. Based on the results of this study, we will design a RCT study with placebo-controlled group.

Conditions

Interventions

TypeNameDescription
DRUGRisperidone
DRUGOlanzapine
DRUGHaloperidole
DRUGQuetiapin
DRUGEscitalopram
DRUGCitalopram
DRUGSertralin

Timeline

Start date
2006-09-01
Completion
2007-08-01
First posted
2007-02-09
Last updated
2007-08-24

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00433121. Inclusion in this directory is not an endorsement.